10 - 11 MARCH Preclinical and Translational Immuno-Oncology
10 - 11 MARCH Immunomodulatory Approaches
10 - 11 MARCH CARs, TILs, TCRs
11 - 12 MARCH Biomarkers for Immuno-Oncology
11 - 12 MARCH Combination Immunotherapy
11 - 12 MARCH Bispecific Antibody Design and Applications
250+
I-O
Thought Leaders
100+
Scientific Presentations
9
Days of Programming
30%
Executive-Level Delegates


2019 Featured Speakers

Christian Klein, PhD
Distinguished Scientist & Head, Oncology Programs, Roche Innovation Center Zurich

Sergio A Quezada, PhD
Professor, University College London Cancer Institute

Roy Baynes, MD
Senior Vice President, Global Clinical Development & CMO, Merck Sharp & Dohme

Ed Schuuring, PhD
Professor & Head, Molecular Pathology, University Medical Center Groningen

Sara Colombetti, PhD
Head of Oncology Discovery Pharmacology, Pharmacology, Roche Innovation Center Zurich

Hinrich Abken, PhD
Professor, Chair Gene-Immunotherapy, Regensburg Center for Interventional Immunology, University Regensburg

Frank Tufaro, PhD
CEO, DNAtrix, Inc.

 

VIEW ADDITIONAL ATTENDEE QUOTES

 

Submit a Speaker Proposal
Attendee Breakdown


ABOUT THE EVENT

Cambridge Healthtech Institute’s Fifth Immuno-Oncology Summit Europe returns to the heart of London’s Canary Wharf for 3 days of cutting edge science and discussion. Through six conference tracks, delegates will hear from the research teams at the forefront of the rapidly developing field of cancer biotherapeutics.